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Abstract
Bacterial peptidoglycan glycosyltransferases (PGT) catalyse the essential
polymerization of lipid II into linear glycan chains required for peptidogly-
can biosynthesis. The PGT domain is composed of a large head subdomain
and a smaller jaw subdomain and can be potently inhibited by the antibiotic
moenomycin A (MoeA). We present an X-ray structure of the MoeA-bound
Staphylococcus aureus monofunctional PGT enzyme, revealing electron den-
sity for a second MoeA bound to the jaw subdomain as well as the PGT
donor site. Isothermal titration calorimetry confirms two drug-binding sites
with markedly different affinities and positive cooperativity. Hydrophobic
cluster analysis suggests that the membrane-interacting surface of the jaw
subdomain has structural and physicochemical properties similar to amphi-
pathic cationic α-helical antimicrobial peptides for lipid II recognition and
binding. Furthermore, molecular dynamics simulations of the drug-free and
-bound forms of the enzyme demonstrate the importance of the jaw subdo-
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main movement for lipid II selection and polymerization process and provide
molecular-level insights into the mechanism of peptidoglycan biosynthesis by
PGTs.
Keywords: bacterial cell wall, lipid II, peptidoglycan synthesis,
glycosyltransferases, jaw subdomain, antibiotic resistance, moenomycin A,
antimicrobial peptide
1. Introduction
The bacterial cell wall is made of peptidoglycan (PG) — a mesh-like
rigid structure that protects bacteria against the high osmotic pressure of
the cytoplasm [1]. PG is synthesized from its precursor lipid II (GlcNAc-
MurNAc(pentapeptide)-undecaprenyl pyrophosphate) by the concerted ac-
tion of membrane-bound enzymes containing the PG glycosyltransferases
(PGT) and transpeptidase (TP) domains [2, 3]. The PGT module is found
in two different families of PG synthases; as a single domain in monofunc-
tional glycosyltransferases (MGTs) and as the N-terminal domain of the bi-
functional class A penicillin-binding proteins (PBPs) [2]. Multiple sequence
alignment of the PGT domain show five conserved sequence motifs (I to V,
Supplementary Figure 1A). Crystal structures of several PGTs, both in the
ligand-free form and in complex with a specific PGT inhibitor moenomycin A
(MoeA, Figure 1A) and/or lipid II analogue [4–13] confirm that these motifs
contain residues important for lipid II binding and catalysis. This essential
function by PGT makes it a potential antibiotic target. Therefore, a thor-
ough understanding of the PGT mechanism would help in the rational design
of novel PGT inhibitors that could be developed as antibiotics [14].
The cell walls of Gram-positive and Gram-negative bacteria differ in the
types of phospholipids they contain, but in both cases, there is a net negative
charge at the membrane surface at physiological pH [15, 16]. Lipid II is also
found in this phospholipid environment but is a low-abundant molecule (less
than 1 percent of total membrane phospholipids) and mostly found in the
regions of membrane close to cell division and elongation [17, 18]. Therefore,
it is important to understand at the molecular level, how PGT domains
selectively capture lipid II molecules from a crowded milieu of membrane
phospholipids.
The PGT domain adopts an all α-helical globular fold with an extended
groove that divides this domain into two subdomains — a large head subdo-
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main containing features similar to the bacteriophage λ-lysozyme [4] and a
small jaw subdomain containing features specific to the glycosyltransferase
family 51 (GT51) (Supplementary Figure 1B). The extended groove forms the
PGT enzymatic cavity and the hydrophobic surface at the base of the jaw
subdomain enables it to embed into the extracellular face of the cytoplasmic
membrane and access the lipid II substrate [4, 19]. Another prominent feature
of the jaw subdomain is a protruding dynamic ‘flap’ region (Supplementary
Figure 1), which is highly disordered in most of the PGT structures, but
resolved in the structures of Staphylococcus aureus monofunctional glycosyl-
transferase (SaMGT) [8, 12], S. aureus penicillin-binding protein 2 (SaPBP2)
[6] and Escherichia coli penicillin-binding protein 1b (EcPBP1b) [13]. The
flap region adopts an α-helix-loop structure and serves as a steric barrier
to physically separate the PGT enzymatic cavity into two substrate-binding
sites — a donor site for the lipid-bound growing glycan chain and an acceptor
site for the lipid II [13]. The flap region has been proposed to play an active
role in the processive catalytic mechanism of PGTs [19–21]. The schematic
models describing the PGT catalytic mechanism suggest that the flap pre-
vents dissociation of the elongating glycan chain and a localized unfolding
or a structural rearrangement of flap regulates the translocation of the elon-
gating glycan chain from the acceptor site to the donor site [5, 6, 13, 22];
however, the actual mechanism of the growing glycan strand translocation
at the active site of PGT is not well understood.
In our exploration of the mechanism of PGT enzymes, we have inves-
tigated and re-refined the 2.1 A˚ crystal structure of MoeA-bound SaMGT
E100Q mutant [Protein Data Bank (PDB) ID code 3HZS] originally solved
by a research team at Pfizer [8]. In addition to the MoeA bound in the
donor site of SaMGT (henceforth referred to as MoeADON) as seen in the
original 3HZS structure, re-refinement has revealed a second molecule of
MoeA bound to the jaw subdomain (henceforth referred to as MoeAJAW ).
Isothermal titration calorimetry (ITC) results revealed positive cooperativ-
ity in binding of two MoeA molecules to PGT. Further, we have used a 2D
hydrophobic cluster analysis (HCA) method and molecular dynamics (MD)
simulations to study the PGT domain and investigate whether any common
structural and physicochemical features shared by the jaw subdomain play a
functional role in the lipid II selection and polymerization process.
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2. Material and methods
2.1. Cloning, Expression and Purification.
SaMGT (residues Q28-R269) was cloned, expressed and purified as de-
scribed previously [12]. Further details in the Supporting Information.
2.2. Isothermal Titration Calorimetry.
Calorimetric titrations of SaMGT with MoeA were performed on a VP-
ITC microcalorimeter (MicroCal) at 25◦C and measured in duplicate. The gel
filtration purified SaMGT was concentrated and dialyzed overnight against
buffer A (20 mM Tris-HCl, pH 8.0, 200 mM NaCl, 2 mM N-decyl-β-d-
maltopyranoside (DM)) at 4◦C. All solutions were degassed by gentle stirring
under vacuum for 15 min. The dialysis buffer A was used to prepare MoeA
solution. The sample cell (1.445 mL) was filled with 20 µM SaMGT and
the syringe (280 µL) with 450 µM of the titrating MoeA. Each ITC experi-
ment consisted of a preliminary 2 µL injection followed by 27 successive 10
µL injections. Each injection lasted 20 s with an interval of 200 s between
consecutive injections. The solution in the sample cell was stirred at 351
rpm throughout the experiment. The heat response data for the preliminary
injection was discarded and the rest of the data was used to generate binding
isotherm. The data were fit using the sequential binding site model included
in the Origin 7.0 (MicroCal). Thermodynamic parameters, including associa-
tion constant (Ka), enthalpy (∆H), entropy (∆S), and binding stoichiometry
(N), were calculated by iterative curve fitting of the binding isotherm. The
Gibb’s free energy (∆G) was calculated using ∆G = ∆H - T∆S.
2.3. Model Building and Structure Refinement.
Re-refinement of MoeA-bound SaMGT E100Q mutant (PDB ID code
3HZS) was performed using the program BUSTER 2.10.2 [23] and model
building was done in Coot [24]. Polder omit maps were calculated using
the phenix.polder tool in the PHENIX software package [25]. Geometrical
restraints for the ligands were generated using the Grade Web Server [26]
and Rhofit program [27] was used for automated fitting of ligands into the
difference electron density.
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2.4. Hydrophobic Cluster Analysis.
The primary sequences of the PGT domain in MGTs and class A PBPs
were converted into hydrophobic cluster analysis (HCA) plots [28] using the
HCA plot server at Mobyle@RPBS [29]. The HCA plot relies on the 2D heli-
cal representation of the amino acid sequence obtained after duplication of an
unrolled cylinder in which the amino acid residues follow a classical α-helical
pattern (3.6 residues per turn). The hydrophobic residues (F, V, L, I, M, Y,
and W) are surrounded by a mosaic and few residues are specially displayed:
P (star), G (diamond), T (square) and S (dotted square). Since the protein
secondary structure is associated with the clusters of hydrophobic residues
in the plot, this method allows distinguishing between the β-strands and α-
helices [30]. Usually, alanine is not included as a part of the hydrophobic
cluster; however, the presence of highly conserved alanine residues in few of
the α-helices in PGT domain suggested us to include this residue, which has
significantly helped in the analysis of the HCA plot. HCA similarity scores
were obtained by calculating the number of hydrophobic amino acids using
the following formula: HCA homology score (%) = [(2CR / RC1 + RC2) x
100], where CR is the number of hydrophobic residues which are in corre-
spondence between the compared sequences and RC1 (RC2) is the number
of hydrophobic residues in protein 1 (protein 2).
2.5. Molecular Dynamics.
The crystal structure of full-length membrane-bound SaMGT (PDB ID
code 3VMT) was used to model the N-terminal transmembrane α-helix in
the apo SaMGT structure and was embedded within a model of S. au-
reus cell membrane containing 57% phosphatidylglycerol (PG), 38% lysyl-
phosphatidylglycerol (Lys-PG), and 5% diphosphatidylglycerol (DPG; also
known as cardiolipin). The lipid composition of this model membrane was
based on experimentally determined values [31, 32] and its structure has been
previously validated [33]. The N-terminal α-helical domain of SaMGT was
inserted into the membrane using the g membed protocol [34]. This sys-
tem was solvated and 0.15 M NaCl was added. A short 1 ns equilibration
simulation was performed whereby the heavy atoms in the protein were posi-
tionally restrained using a force constant of 1000 kJ mol−1. The temperature
was kept at 310 K using the velocity rescale thermostat with a time constant
of 0.1 ps [35]. The pressure was maintained at 1 atm using a semi-isotropic
coupling to the Parrinello-Rahman barostat using a time constant of 1.0 ps
[36]. The particle mesh Ewald method was used to calculate the electrostatic
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interactions, whereby a real-space cut-off of 0.9 nm was utilised [37]. The van
der Waals interactions were truncated at 1.4 nm with long-range dispersion
correction applied to the energy and pressure. All bonds were constrained
using the LINCS algorithm to allow for a 2 fs time step [38]. After the
equilibration, the positional restraints on the heavy atoms were removed and
three independent production runs, each for 500 ns, were performed at 310
K (Table S2). One simulation was performed at a higher temperature of 323
K for 750 ns to accelerate the dynamics. The MoeA molecule was param-
eterised using the Automatic Topology Builder [39]. The MoeADON bound
SaMGT was then equilibrated inside the S. aureus membrane model using
the same protocols described for the apo protein. Three independent 500
ns simulations were performed with this protein-ligand complex at 310 K.
All simulations were performed using the GROMACS package version 4.6.7
[40, 41], the GROMOS 54A7 force field [42], and the SPC water model [43].
Built-in GROMACS analysis tools and VMD [44] were employed to analyse
the trajectories.
3. Results
3.1. Re-refined structure of the MoeA-bound SaMGT E100Q mutant (PDB
ID code 3HZS).
The authors of the high-resolution crystal structure of the MoeA-bound
SaMGT E100Q mutant (PDB ID code 3HZS) [8] reported a tightly ordered
phosphate ion bound in a pocket (formed by residues His107 to Leu112)
at the base of the jaw subdomain that they proposed could represent the
binding site for the pyrophosphate (PP) moiety of the acceptor lipid II sub-
strate, however the authors did not use any phosphate containing salts in
the SaMGT purification and/or crystallization experiments. This prompted
us to re-examine 3HZS structure to resolve this apparent discrepancy. Our
re-analysis has revealed several positive difference electron density features,
which we manually inspected to interpret the electron density and identify
appropriate ligands that could be correctly modelled into these features, re-
sulting in an updated model (PDB ID code 6FTB) with improved overall
statistics from the original as shown in Supplementary Table 1.
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Figure 1: (A) Structure of moenomycin A (MoeA). (B) Overall view of the re-refined
structure of SaMGT E100Q mutant with bound MoeA (PDB ID code 6FTB). The jaw
subdomain is colored yellow and head subdomain is colored orange. MoeADON (green) is
shown in stick representation and MoeAJAW (pink) is shown in ball-and-stick represen-
tation. Polder electron density map [25] for MoeADON (grey mesh) and MoeAJAW (blue
mesh) is contoured at 2σ. Unmodelled parts of MoeAJAW (due to no visible electron
density) is shown in gray colored line representation. (C) SaMGT with bound lipid II
analog (cyan colored shown in stick representation) in the acceptor site (PDB ID code
3VMT) and the PGT domain of Aquifex aeolicus PBP1A (PDB ID code 2OQO) with
bound CHAPS (black colored shown in stick representation) are superimposed on 6FTB.
Only 6FTB (gray colored cartoon) is shown for clarity. MoeADON and MoeAJAW are
shown as in B. PGT motifs I to V (colored red) and flap (colored yellow) is shown.
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The difference map produced by the phenix.polder tool in PHENIX [25]
shows for the first time a complete C25 moenocinol lipid tail of MoeADON
modelled into the structure (Figure 1B). The saccharide ring D of MoeADON
has been marginally shifted to fit accurately into the electron density (Sup-
plementary Figure 2A) and this improved fitting subsequently revealed a
bifurcated electron density extending from the C2 carbon atom of ring D sug-
gesting that the functional group at this position is not OH, but an unknown
functional group that would make a bifurcated hydrogen bonds to the oxygen
atoms of the phosphate moiety and saccharide ring F (Supplementary Figure
2B). None of the MoeA derivatives currently known explain this potential
adduct [45]. Additional electron density was observed in the groove accom-
modating ring A of MoeADON which is consistent with a non-ionic surfactant:
glyceryl monolaurate (Supplementary Figure 2C) used during cell lysis pro-
cedure [8]. The polar end of glyceryl monolaurate makes strong hydrogen
bond interactions with the side chains of Asp184, Tyr196 and the backbone
atoms of Pro226, Ser227, Val228, Tyr229 and Asn230. These residues are
part of a patch of conserved residues in the head subdomain of the GT sur-
face, which is probably of functional significance (Supplementary Figure 2C).
Structural superimposition showed that glyceryl monolaurate binds in a dif-
ferent pocket than the CHAPS bound to the PGT domain of Aquifex aeolicus
PBP1A (PDB ID code 2OQO) (Figure 1C) [5].
Our analyses also revealed a large positive electron density extending
from the bound phosphate ion at the base of the jaw subdomain (His107 to
Leu112), along the external surface connecting to an additional area of pos-
itive electron density at the mouth of a deep pocket just below the catalytic
site (Figure 1B). This deep pocket is surrounded by the conserved residues
in what we now define as motif I (Asp101, His107, Gly109, Asp111), motif II
(Gln129, Gly130, Gly131, Ser132, Thr133, Gln136) and motif III (Lys153),
suggesting its functional significance. The difference density from the polder
map was sufficient to fit the A and B rings of MoeA at the mouth of the deep
pocket and ring F connecting the bound phosphate ion at the base of the jaw
subdomain (Figure 1B). Saccharide rings C, D, E and the C25 moenocinol
lipid tail could not be modelled due to a lack of significant difference den-
sity. The overall electron density suggested that sections of a second MoeA
molecule (i.e. MoeAJAW ) bound to the jaw subdomain could be modelled at
this site. Strikingly, the tail of the CHAPS molecule in 2OQO occupies the
same position in space as the A and B rings of MoeAJAW and the steroidal
ring of CHAPS occupies approximately the same space as rings C, D and E of
8
  
MoeAJAW (Figure 1C). Superimposing the structure of lipid II analog-bound
SaMGT (PDB ID code 3VMT) onto 6FTB showed that the A and B rings
of MoeAJAW snuggly fit in a pocket adjacent to the lipid II analog (bound
in the acceptor site) and the motif II residues (Gly130 to Ser132) act like a
steric barrier to separate this well-conserved pocket from the catalytic site
(Figure 1C). The ring B of MoeAJAW forms hydrogen bonds with the side
chains of Asp101, Gln136, the backbone carbonyl oxygen atom of Phe110
and the water molecules in the pocket.
No other changes were found in the protein chain overall except for ex-
tension of the map at the N-terminus by one residue so that Glu59 is now
included. Superimposition of the original (PDB ID code 3HZS) and re-refined
(PDB ID code 6FTB) SaMGT-MoeA structures yield a root-mean-square de-
viation (RMSD) of 0.092 A˚ over the Cα atoms of the 208 amino acid residues.
3.2. Positive cooperativity in binding of MoeA to PGT.
Discovery of MoeAJAW bound in the jaw subdomain of the 3HZS struc-
ture prompted us to characterize the binding of MoeA to wild-type full-
length SaMGT. We used isothermal titration calorimetry (ITC) to measure
the association free energy (∆G) and its enthalpic (∆H) and entropic compo-
nents (∆S) for MoeA binding to SaMGT. The biphasic nature of the binding
isotherm (Figure 2) clearly points to two non-equivalent sites in SaMGT with
a significant difference in binding affinity for MoeA.
Macroscopic apparent binding affinities were determined to be Kapp1 of
3.56·105 ±2.7·104 M−1 and Kapp2 of 1.87·10
6 ±1.1·105 M−1. Due to statisti-
cal effects, it would be expected that Kapp1 = 4·Kapp2. However, it can be
seen that Kapp1 ≈
1
5
Kapp2 indicating positive cooperativity. As noted by
Velazquez-Campoy and co-workers [46] we can calculate the intrinsic bind-
ing constant (k) and cooperativity factor (α) for a cooperative binding event
from the apparent binding constants as:
Kapp1 = 2k
Kapp1Kapp2 = αk
2
giving values of k = 1.78·105 ±1.4·104 M−1 and α = 21.3. As α > 4, this
demonstrates positive cooperativity. The measured enthalpy change between
the two binding steps, ∆H1 - ∆H2, is +1.8 kcal mol
−1. Thus, binding of
MoeAJAW is accompanied by a favourable enthalpy change.
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Figure 2: Energetics of cooperative sequential binding of MoeA to SaMGT. ITC heat
response (top) and binding isotherm (bottom) of the calorimetric titration of MoeA into
SaMGT. A cartoon representation of SaMGT (head subdomain colored orange and jaw
subdomain colored yellow) and MoeA (pink) is shown in the bottom chart. The solid line
in the bottom chart represents the fit to a sequential binding site model. The dissociation
constant (Kd) for the MoeAJAW and MoeADON binding steps are 2.8 µM and 0.54 µM,
respectively.
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3.3. Structural similarity between the PP-binding motifs of PGT jaw subdo-
main and antimicrobial peptides.
The hydrogen bond interactions between the phosphate ion of the MoeAJAW
and the backbone atoms of the well-conserved motif I residues implies the
presence of a common PP-binding structural motif in all PGT enzymes for
lipid II recognition and binding (Supplementary Figure 1 and see Discussion).
To characterize the function of the PP-binding motifs in PGT enzymes, we
used the Omokage shape similarity search (https://pdbj.org/emnavi/omo-
search.php) [47] to scan the PDB for proteins with overall fold similarity for
PP binding. The first search for the segment covering motif I–flap region of
SaMGT (residues Arg103-Thr116 in PDB ID code 3HZS) revealed the solu-
tion structures of cysteine deleted protegrin-1 (CDP-1, PDB ID code 2MQ2)
[48] and a nontoxic bacterial membrane anchor peptide (PDB ID code 1VM4)
[49] as the best hits, suggesting its possible role in membrane perturbation
and anchoring (see following section). Remarkably, the second search for the
segment covering the “tip” region of the flap of SaMGT (residues Arg117-
Val128 in PDB ID code 3HZS) revealed the solution structures of the cationic
antimicrobial peptide (AMP) nisin-lipid II complex (PDB ID code 1WCO)
[50], mersacidin-lipid II complex (PDB ID code 1MQZ) [51] and the X-ray
crystal structure of racemic plectasin (PDB ID code 3E7R) [52] as the top-
most hits. For simplicity and clarity in understanding, we will restrict our
comparison of the flap region of PGTs with the nisin-lipid II complex (Figure
3).
The N-terminal part of nisin (residues 1-12) adopts a unique nest-like
motif called “PP cage” to bind the PP moiety of lipid II by hydrogen bonds
from the amide groups of the nisin backbone (Figure 3A) [50]. Deleting
the C-terminal tail of the peptide inhibits the pore forming activity of nisin
but still maintains its lipid II PP-binding ability [53]. We found a striking
similarity between the “PP cage” motif of nisin and the “tip” region of the
flap of SaMGT (Figure 3A and 3C) and equivalent residues in PGTs of
SaPBP2 (Figure 3B) and EcPBP1b. A key notable difference is that the
“PP cage” motif follows N- to C- direction in nisin and C- to N- direction in
PGTs. Superimposition of the PDB ID code 3VMT (lipid II analog bound in
the acceptor site of SaMGT) and 3HZS show that the PP moiety of the lipid
II analog comes very close to binding the PP cage-like motif at the “tip” of
the flap (Figure 3C).
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Figure 3: Structural similarity between the PP-binding motif in the cationic antimicro-
bial peptide nisin, Staphylococcus aureus penicillin-binding protein 2 (SaPBP2) and S.
aureus monofunctional glycosyltransferase (SaMGT). (A) Solution structure of nisin-lipid
II complex (PDB ID code 1WCO). The N-terminal part of nisin (residues 1-12 colored
orange) encages the PP moiety of lipid II (colored green). (B) Flap segment of SaPBP2
(residues 126-141 in chain B of PDB ID code 3DWK colored green) interacts with the acyl
tail of lauryldimethylamine N-oxide (LDAO, colored blue). (C) Flap segment of SaMGT
(residues 104-128 in PDB ID code 6FTB colored pale yellow) with bound MoeAJAW (col-
ored pink) and modelled lipid II analog (colored cyan) by superpositioning with PDB ID
code 3VMT.
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3.4. Hydrophobic cluster analysis of the PGT domain.
Multiple sequence alignment of the PGT domain in MGTs and Class A
PBPs show conserved amino acids in the motifs I to V, whereas the rest of the
protein sequences share low levels of sequence identity, especially in the flap
segment (only one conserved alanine in the α-helix, Supplementary Figure
1A). 3D-structures of SaMGT (PDB ID code 3HZS, [8]), SaPBP2 (PDB
ID code 3DWK [6]) and EcPBP1b (PDB ID code 5HLB [13]) have shown
that despite low sequence identity, the flap adopts an α-helix-loop structure.
Simple 1D sequence comparison cannot be used to study the protein domains
showing very limited amino acid relatedness. In such cases, 2D hydrophobic
cluster analysis (HCA) method [28–30] has successfully identified conserved
regions including motifs of functional significance in β-glycosyltransferases
[54] and catalytic residues in glycosyl hydrolases [55]. Here, we have used
the HCA method to study the PGT domain in MGTs and class A PBPs.
A 2D HCA plot showed that nine hydrophobic clusters (C1 to C9) cover
the entire PGT domain (Figure 4 and Supplementary Figure 3). Clusters
C1 and C6 to C9 are part of the head subdomain and clusters C2 to C5 are
part of the jaw subdomain. In particular, our HCA analysis has identified
three new motifs in the head subdomain that we are proposing for the first
time - cluster C1 (motif 0), cluster C7 (motif IVa) and cluster C8 (motif
IVb). Comparison of the HCA plots revealed a similarity in the shapes
and patterns of the clusters made by the hydrophobic residues suggesting
their structural and functional roles. The four highly conserved hydrophobic
clusters C1, C2, C4 and C6 (HCA homology score > 90%) make the core of
the PGT domain. Clusters C3, C7, C8 and C9 are highly divergent in terms
of their precise shape; nevertheless, arrangement of few hydrophobic residues
is roughly the same, which gives a minimal pattern to these clusters (Figure
4 and Supplementary Figure 3).
Clusters C3 and C5 belong to the flap segment and motif III respectively
and form the base of the jaw subdomain that make direct contacts with the
membrane-anchored lipid II substrate. A notable feature of these two clusters
is the presence of charged and polar residues in the vicinity of the hydrophobic
residue clusters. Additionally, the shapes of the hydrophobic clusters C3 and
C5 indicate a strong preference for α-helical structures, which agrees with
the 3D structures of the PGT domain. Taken together, this suggests that
the flap and motif III α-helices have amphipathic properties (Figure 5B),
making the membrane-interacting surface of PGTs amphiphilic for proper
adsorption onto the membrane surface to access lipid II substrate.
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Figure 4: Aligned HCA plots of the PGT domain in monofunctional glycosyltransferases
(MGTs) and class A penicillin-binding proteins (PBPs). Only three sequences are shown
here due to space limitations. UniProt accession numbers: Staphylococcus aureus MGT
(SaMGT, Q7A0I6), S. aureus PBP2 (SaPBP2, Q9R744) and Enterococcus faecalis PBP1b
(EfPBP1b, I3U3N7). A comprehensive HCA plot with more aligned sequences is shown
in Supplementary Figure 3. The standard one-letter code for amino acids is used except
for glycine (), proline (F), serine ( ) and threonine () respectively. The vertical lines
indicate proposed correspondence between the compared sequences. The strictly conserved
residues (in the multiple sequence alignment Supplementary Figure 1A) are indicated
with a black circle. The conserved and conservatively substituted amino acids within the
hydrophobic clusters (shaded in gray) suggest a structural and functional relationship. †
indicates motifs identified in this study.
3.5. Similarity in the physicochemical properties of the membrane-interacting
surface of the PGT jaw subdomain and amphipathic cationic α-helical
AMPs.
The structural similarities between the PP-binding motifs in the flap of
SaMGT and AMP nisin prompted us to analyze and compare the physico-
chemical properties of the membrane-interacting surface of the jaw subdo-
main with the amphipathic cationic α-helical (ACAH) AMPs in the Mag-
ainin family – the largest known group of ACAH AMPs (Figure 5A). The
bacteria-killing activity of ACAH AMPs by segregation of anionic lipids in
bacterial membranes through a “charge cluster” mechanism depends on two
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Figure 5: Comparison of the structural and physicochemical features between (A) the
cationic α-helical AMP Magainin and (B) the membrane-interacting surface (flap and
motif III) of the jaw subdomain in PGT. In both a and b, the upper panel (1D) shows the
amino acid sequence, the middle panel (2D) shows the hydrophobic cluster analysis plot
and the lower panel (3D) shows the 3D structure with surface representation and amino
acid (hydrophobic coloured red and positively charged coloured blue) side chains shown
as sticks.
physicochemical properties: an overall cationic nature for selective recogni-
tion of negatively charged target moieties on the cytoplasmic membrane and
hydrophobicity for interaction with the fatty acyl chains of phospholipids
[56, 57].
A 2D HCA of Magainin revealed a distribution pattern of hydropho-
bic and positively charged residues describing the conserved structural and
physicochemical properties of ACAH AMPs (Figure 5A). Remarkably, we
found a strikingly similar 2D pattern by assembling the HCA plots of the
flap and motif III of the PGT jaw subdomain close to each other (Figure
5B). This minimal 2D pattern of the flap and motif III can be found in the
HCA plots of the PGT domain in MGTs and class A PBPs (Figure 4 and
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Figure 6: RMSF of SaMGT during MD simulations. (A) Average RMSF values of the
α-carbons of apo SaMGT from three 500 ns simulations at 310 K mapped on its structure
in ribbon representation. (B) This RMSF values compared to the ones from MoeADON -
bound simulations, with the flap, motif III, and motif IVb highlighted.
Supplementary Figure 3), suggesting that this possibly could be a minimal
structural motif and a physicochemical feature for phospholipid recognition
and the neighboring residues in the flap and motif III would help in attaining
selectivity or specificity for lipid II substrate. Unfortunately, we could not
perform a similar analysis on nisin family due to the presence of lanthionine
bridges and several post-translationally modified amino acids, which make
it difficult to characterize their physicochemical properties and for 2D HCA
analysis.
3.6. Molecular dynamics analysis of the PGT domain.
3.6.1. The flap region is highly dynamic in apo and MoeA-bound simulations.
The flexibility of the full-length SaMGT within the membrane was an-
alyzed by measuring the root-mean-square fluctuation (RMSF) of the α-
carbons throughout the 500 ns simulations. Due to the persistent interactions
with phosphate groups within the membrane, most of the jaw subdomain was
relatively rigid compared to the more solvent-exposed head subdomain (Sup-
plementary Figure 4).
Part of the flap region (residues Phe120 to Gln129), however, was signif-
icantly more flexible than the rest of the jaw subdomain, with the RMSF
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values reaching 4 A˚ (Figure 6). These residues were exposed to the bulk so-
lution and did not contact the membrane unlike the rest of the flap and motif
III. With the MoeADON bound in the active site cleft, these residues in flap
remained flexible as no significant interactions were formed between them.
Another part of the protein that was highly mobile was motif IVb (residues
Ala225 to Ser235) in the head subdomain. Unlike the flap, however, these
residues were stabilised by the binding of MoeADON , suggesting that motif
IVb residues are important for the MoeA binding to the donor site of the
SaMGT catalytic cleft.
3.6.2. The flap region flips towards motif III in extended simulations.
The flap region, in particular the soluble and structurally disordered part
(residues Phe120 to Gln129), moved in a stochastic manner, i.e. the flap
either flipped towards or away from motif III. In one of the 500 ns simulations,
we found a significant motion towards motif III, such that some of its residues
shifted as far as 10 A˚ from the crystal structure (Figure 7). We explored
this further by performing one simulation at a higher temperature of 323
K to accelerate the dynamics of the system, and for a longer time scale of
750 ns. This simulation showed an even larger motion of the flap, whereby
the flexible part moved around 15-20 A˚ from its original position towards
motif III. Comparing the RMSF values at the beginning and at the end of
the simulation indicated that this flipping motion stabilised the flexible flap
region, whereby at the end of the simulation the RMSF was reduced from 4
A˚ to 1 A˚. The distance between two reference residues (Thr122 on the flap
and Phe150 on motif III) remained around 10 A˚ during the last 350 ns of the
simulation, further corroborating the stabilising effect of this motion towards
the flap region. It is possible that under a biological condition, this large
conformational change occurs at a longer time scale, perhaps microsecond,
which explains why it is only observed in one of the original simulations
and requires a higher temperature to further induce this motion. Overall in
the apo configuration, the jaw subdomain prefers to be in a resting state,
whereby the flap and motif III are in close proximity to each other.
3.6.3. MoeA binding in the donor site was stable throughout the simulations.
MoeADON remained bound to the SaMGT catalytic cleft throughout all
three 500 ns simulations, whereby most of the interactions were via residues
in motif IVb (residues Asn224-Ser227), Lys140 and Asn141 (Figure 8). The
polyprenyl chain of MoeADON was stabilised by hydrophobic interactions to
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Figure 7: The motion of the flap towards motif III in apo simulation. (A) Snapshots of
SaMGT at the beginning and at the end of a 750 ns simulation at 323 K from the plane of
the inner membrane (left) and from the extracellular side (right). Two residues found in
the flap and motif III (T122 and F150, respectively) are shown in licorice representation
and colored pink (0 ns) or cyan (750 ns). (B) The minimum distance between T122 and
F150 during three 500 ns simulations at 310 K (dotted line), and one extended 750 ns
simulation at 323 K (solid line), as indicated by the arrow in (A). (C) α-carbon RMSF
values at the beginning (red) and at the end (blue) of the 750 ns simulation with the
positions of the flap, motif III, and motif IVb highlighted.
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Phe150 in motif III, the phosphate group formed salt bridges with Lys140
and Arg148, whilst the sugar moieties bound to several polar residues like
Asn141, Tyr176 and Tyr181. Looking at the number of residues in contact
with MoeADON throughout the simulations, we found only a small degree
of fluctuation in two of these simulations, indicating a strong and stable
binding. Interestingly in one of them, the number of residues in contact with
MoeADON increased significantly towards the end of the simulation. Upon
further inspection, we found the flap moved around 10 A˚ towards MoeADON
resulting in more residues in contact with the ligand. This behaviour is
similar to the apo simulation, although the presence of MoeADON between
the flap and motif III prevented these two regions from approaching each
other to the same degree. As such, in the presence of MoeADON , the jaw
subdomain remains open and the flap is likely to be flexible due to the lack
of interactions with motif III.
4. Discussion
4.1. Recognition and binding of lipid II by PGT enzymes.
The schematic models describing PGT processive catalytic mechanism
for glycan strand synthesis [5, 12, 13] generally consider that, to start the
catalytic cycle, the donor and the acceptor sites will be occupied by the re-
spective lipid II molecules. However, lipid II is a low-abundant molecule in
comparison with the different types of phospholipids present in several fold
access in the bacterial cell membrane. Thus, none of the proposed schematic
models provide an obvious explanation for how the PGT enzymes access the
membrane-bound lipid II and selectively capture them into the active site.
Crystal structures of several PGTs [4–13] suggest that the motifs I, II, III and
flap region of the jaw subdomain interact with the cytoplasmic membrane in
a region distinct from the transmembrane α-helix and are required for the
recognition of lipid II. In vitro experiments by Thierry Vernet and co-workers
on the PGT domain of Streptococcus pneumoniae PBP1b [58] and PBP2a [59]
showed that motif I stabilizes the PGT domain and together with motif II
play a crucial role in the efficient recognition and binding of lipid II. In our re-
refined model (PDB ID code 6FTB), residues Asp101 (motif I) and Gln136
(motif II) make hydrogen bond interactions with MoeAJAW and mutating
these residues Asp101Asn and Gln136Glu abolished lipid II polymerization
activity [8]. Our HCA analysis of the PGT domain in MGTs and class A
PBPs (Figure 4 and Supplementary Figure 3) revealed that placing the flap
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Figure 8: The binding of MoeADON to SaMGT. (A) Residues that were in contact with
MoeADON averaged over three 500 ns simulations. A score of 1 indicates residues that
interacted with MoeADON throughout the entire simulation, and 0 indicates no contact.
Residues that scored 0.8 and above are labelled. (B) The number of residues that bind to
MoeADON during the three simulations. Highlighted in red is the portion of one simulation
whereby the flap interacted with MoeADON . A distance cut-off of 4 A˚ was used during
these contact analyses. (C) Snapshots of MoeADON -bound SaMGT at the beginning and
at the end of one of the simulations. MoeA is shown in van der Waals representation.
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and motif III in close proximity produces a 2D pattern of hydrophobic and
positively charged residues describing a conserved structural and physico-
chemical properties similar to ACAH AMPs (Figure 5). This possibly could
be a minimal structural motif and a physicochemical feature of the jaw sub-
domain for phospholipid recognition and that the other neighboring residues
in the flap and motif III may help in attaining selectivity or specificity for
lipid II. Further, the stochastic movement of the flap closer to or away from
motif III in our MD simulations is suggestive of a charge cluster-like mecha-
nism by the jaw subdomain to segregate lipid II substrate from the crowded
milieu of other phospholipids in the bacterial membrane (Figures 7 and 8).
Most AMPs are thought to be linear and unstructured in aqueous so-
lution and adopt a stable amphipathic conformation in the membranous
environment for making target substrate specific interactions [56]. This dy-
namic behavior (folding and unfolding property) of AMPs is necessary for
the fine-tuning of structural parameters (peptide conformation, hydropho-
bicity, hydrophobic moment, peptide charge and the size of the hydropho-
bic/hydrophilic domain) to attain substrate selectivity and specificity. Most
of the crystal structures of PGT in apo form or in complex with MoeA show
an unstructured flap and weak electron density for the motif III α-helix, in-
dicating the dynamic nature of the jaw subdomain at the membrane-water
interface. This suggests that, like AMPs, the flap and motif III seem to re-
quire a membranous environment to maintain the secondary structure and
stability for efficient lipid II binding and elongation mechanism. MD analysis
showed that the jaw subdomain was relatively rigid through stable interac-
tions with phosphate groups embedded in the membrane (Supplementary
Figure 4). Likewise, the presence of dimethyl sulfoxide (DMSO), which is
a good membrane-mimicking solvent [60] for increased solutbility of lipid II
substrate and to facilitate faster exchange between detergent micelles, showed
a strong influence on the in vitro PGT assay [61, 62].
Our discovery of MoeAJAW bound to the SaMGT jaw subdomain by
X-ray crystallography (Figure 1B) strongly suggests a re-evaluation of the
hypothesis proposed by Heaslet et al. that a lipid II could bind in the pocket
where phosphate ion was modeled in the PDB ID code 3HZS [8]. Hydrogen
bond interactions between the phosphate ion of MoeAJAW and the backbone
atoms of the well-conserved motif I residues implies the presence of a com-
mon PP-binding structural motif in all PGT enzymes for lipid II recognition
and binding (Supplementary Figure 1). In the re-refined SaMGT model, the
ring A and B of MoeAJAW occupies the same pocket as the Mg
2+ ion in the
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structure of SaMGT bound with lipid II analog in the acceptor site (PDB
ID code 3VMT, chain A) [12] suggesting a significant functional role(s) for
this pocket made by the motifs I, II and III. The motif I PP-binding site
in the PGT jaw subdomain is structurally similar to the “PP cage” motif
of nisin. Nisin binds to lipid II by docking onto the the PP moiety [18, 63]
because the PP group remains stably anchored at the lipid-water interface
in the same plane as the phosphate groups of the other membrane lipids,
whereas the lipid II polar head-group (GlcNAc-MurNAc) and the hydropho-
bic bactoprenol tail are dynamic and display a high degree of conformational
heterogeneity [64, 65]. This suggests that the PGT jaw subdomain would use
the motif I PP-binding site for docking onto the PP moiety of the substrate
(lipid II or lipid IV) to properly anchor onto the membrane surface. The
docking may help the PGT domain to achieve a slight stiffening to control
the global dynamic motions, which in turn would allow the PGTs to position
their active site at the correct height from the membrane surface to interact
with the polar head-group of the lipid II substrate. MD analysis showed
that the residues in the “tip” of the flap made contacts with the phosphate
groups of the lipids embedded in the membrane (Supplementary Figure 4),
which further corroborates that the flap segment can partially insert into the
membrane bilayer to access lipid II. Such a mode of binding of the PP moiety
would allow the bactoprenol tail of the lipid II to stabilize against the con-
tinuous hydrophobic surface (residues Phe110, Leu112, Leu119 and Phe120
in SaMGT) along the axis of the flap α-helix, similar to the acyl tail of the
detergent lauryldimethylamine N-oxide (LDAO) stabilized by hydrophobic
interactions from residues in the SaPBP2 flap α-helix (Figure 3B) [6]. The
backbone amide atoms of Phe110 and Leu112 are essential for lipid II bind-
ing [8] and a double mutation Leu119Asn-Phe120Ser in SaMGT abrogates
its interaction with lipid II and MoeA and a complete loss of specific MoeA
binding at the donor site [22].
4.2. Positive cooperativity and allostery in the PGT active site.
The interaction of MoeA and other potential PGT inhibitors to full-length
and truncated variants of class A PBPs and MGT has been extensively stud-
ied using various techniques: nuclear magnetic resonance [66, 67], surface
plasmon resonance (SPR) [22, 68, 69], fluorescence anisotropy [69] and ITC
[12]. Studies have shown that the PGT transmembrane α-helix contributes
to the MoeA binding in the PGT active site[12, 69]. SPR data analysis of
MoeA binding to immobilised full-length EcPBP1b by fitting to a 1:1 in-
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teraction model resulted in a Kd of 0.44 µM [69]. Interestingly, the SPR
data analysis of full-length SaMGT binding to immobilised MoeA showed a
clear inhibition of SaMGT binding by MoeA at 0.5 µM concentration, but
the binding curves could not be reconciled by a 1:1 interaction model [22].
The ITC experiment by Che Ma and co-workers showed a Kd of 0.2 µM
for MoeA binding to full-length SaMGT, but the authors did not report a
binding stoichiometry [12]. To resolve this apparent discrepancy in binding
stoichiometry and to verify the observation of the second MoeA in our re-
refined structure (PDB ID code 6FTB), we performed ITC of MoeA binding
to full-length SaMGT. Our ITC data has shown two MoeA binding events
with positive cooperativity in the SaMGT active site (Figure 2). Further, in
our ITC data analyses, the MoeA binding isotherm could only be fitted using
a sequential binding site model (Figure 2) and the apparent Kd of 0.54 µM
observed for the MoeADON binding event. Based on the SPR results, Bury et
al. proposed that lipid II analogs, at low concentrations, preferentially bind
to the acceptor site and stabilize the flap region resulting in a structural
rearrangement to increase the affinity of the donor site to MoeA (supposed
to mimic the growing glycan chain / lipid IV). This suggested a positive
cooperativity between the acceptor and the donor sites and an allosteric ac-
tivation of donor site in PGTs [22]. In contrast, our MD analysis of the apo
SaMGT model show that in the resting state, the flap is flexible and prefers
to be positioned closer to motif III (Figures 7 and 9, and PDB ID code 3DWK
chains B and C) and in this conformation the acceptor site is not available for
lipid II binding. In vitro experiments using the synthetic lipid II and lipid IV
derivatives have shown that the formation of first lipid IV is the rate-limiting
step in PG synthesis, probably because lipid II is not an optimal substrate
in the donor site for the initiation step and that the rate-limiting step can
be changed using longer glycan strands such as lipid IV [70]. Moreover, lipid
IV in isolation has been shown to be a substrate for PGT enzymes [70, 71].
This suggested that binding of lipid IV in the donor site induces structural
rearrangements, including probably in the acceptor site that enhances the
binding of lipid II during the elongation phase of processive glycan chain
polymerization [21]. MD analysis of the apo SaMGT model suggests that
the dynamic movements of the motif IVb (Figure 6) would prevent lipid II
from binding to the donor site and this could be the possible reason behind
the rate-limiting step during the initiation step. SaMGT pre-incubated with
Gal-lipid IV enhanced the lipid II polymerization reaction rate by >6-fold
as measured by an in vitro PGT polymerisation assay [70]. Interestingly,
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in our ITC experiment measuring binding affinities, the MoeAJAW binding
enhanced the MoeADON binding by ≈20-fold (Figure 2). Taken together,
we propose that our newly discovered MoeAJAW -binding site, upon binding
either lipid II or lipid IV, may induce allosteric motions to reorganize the GT
active site and maintain the positive cooperativity between the donor and
acceptor sites throughout the lipid II polymerization process. This would re-
sult in increase in the affinity of the donor and acceptor sites for lipid II in the
initiation step and the substrate binding would shift the dynamic equilibrium
by preferentially stabilising a particular motion between the head and jaw
subdomains for processive glycan chain elongation. Additionally, we believe
that our re-refined SaMGT-MoeA model (PDB ID code 6FTB), specially
the MoeAJAW bound in the jaw subdomain, may help in the structure-based
design and development of novel PGT inhibitors.
4.3. Mechanistic hypothesis for processive lipid II polymerization by PGT.
Based on the above observations (including the amino acid mutations
within the active site and jaw subdomain [8, 22]), we now propose a mecha-
nistic hypothesis for the processive lipid II polymerization by PGTs (Figure
9). Our MD data indicate that in the substrate lipid II unbound state (rest-
ing state), the flap and motif III lie in close proximity to each other. This,
we speculate, would enable the jaw subdomain to build a high local density
of positive charge for anionic lipid II accumulation closer to the PGT active
site. PGT jaw subdomain docking onto the PP moiety of the membrane-
embedded lipid II/lipid IV would be the primary driving force behind – (i)
the global structural rearrangement of the PGT active site for increased lipid
II affinity (activation state) and (ii) the coupling of the head- and the jaw
subdomain concerted motion to regulate the movements of the conserved
motifs I-V and allosteric switch between the open and closed conformations
of the flap throughout the lipid II polymerisation cycles until termination.
A key motion for the processive function would be the swaying action of the
flap region towards (closed) and away (open) from the motif III (Figure 9).
Flap opening would carry along with it, a lipid II molecule at the glycosyl
acceptor site and allowing another lipid II molecule to bind into the glycosyl
donor site, in quick succession, resulting in a pre-catalytic complex. The
departure of the C55-PP leaving group from the donor site upon formation
of a new β-1,4-linked GlcNAc-MurNAc (catalysis state) followed by the flap
closing motion, presumably to attain the resting state, would result in the
translocation of the polymerized glycan strand from the acceptor site to the
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donor site. In one of our MD simulation studies, the flap moved closer to
MoeADON (supposed lipid IV analog) bound in the donor site (Figures 8B
and 8C), further corroborating this motion. The occupancy of the donor site
would signal the flap to switch to an activation state, carrying a new lipid
II molecule at the glycosyl acceptor site for another cycle of transglycosy-
lation reaction thereby facilitating the processive glycan chain synthesis. In
conclusion, we propose that a concerted structured and unstructured move-
ment between the head subdomain (motif IVb) and the jaw subdomain (flap)
would be essential to accommodate the elongating glycan strand in the active
site cleft during the translocation step and for pushing the elongating gly-
can strand out of the exit channel for subsequent transpeptidase crosslinking
reactions by class A and/or class B PBPs.
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Figure 9: Hypothetical model illustrating the processive mechanism of lipid II polymeriza-
tion by PGT. Structure of lipid II is shown in the inset. Cartoon representation of PGT
(α-helices shown as cylinders) showing the head subdomain (colored orange) and the jaw
subdomain (colored yellow). The key active site residues are shown as sticks and coloured
by atom type. The flap and motif III helices are labelled. The putative allosteric site is
shown as a star (colored pink). The movement of the flap to show open and closed orien-
tation is indicated by arrows (colored yellow). PGT conformer representing the respective
functional state approximate the select experimentally determined PGT structures and
are annotated as follows: Resting and Translocation (PDB ID code 3DWK chains B and
C), Allosteric Intermediate (PDB ID codes 3VMQ chain A, 2OQO), Activation, Catalysis
and New Lipid II (PDB ID codes 3HZS, 3VMT chain A).
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